An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy

Note:

*click on 'pdf' to access the full paper (free)
* this paper is not specific to neuropathy as a treatment related adverse effect of cancer therapies
* it is written in fairly easy to understand language
* discusses side effects

Low-dose gabapentin as useful adjuvant to opioids for neuropathic cancer pain when combined with low-dose imipramine

Medical News: Gabapentin Studies for Off-Label Uses Cooked? - in Neurology, Pain Management from MedPage Today

"Because the outcomes we examined were fiddled with to some extent, we don't know what the outcome was for the primary outcome that was originally set," she said.

"If I were a physician, or a patient, I would be thinking, what is the true evidence base here?"